Publication | Closed Access

Phase 1 Dose Escalation of Stereotactic Body Radiation Therapy and Concurrent Cisplatin for Reirradiation of Unresectable, Recurrent Squamous Cell Carcinoma of the Head and Neck

Cancer TherapeuticsRadiation TherapyDose EscalationMedicineHead And Neck CancerNeck OncologyOncologyRadiation OncologyPhase 1Concurrent CisplatinRadiologyHealth Sciences